Addressing HSDD with Medical Intervention

Addyi is believed to work on the drive center of the brain, which results in more desire for sex, less distress and ultimately more satisfying sex. Once women and doctors know how Addyi works, they understand the many ways in which Addyi isn’t about being on demand for a sexual act at all. It’s about that desire/stress center of the brain being in an optimal place when the moment is right. HealthyWomen: Have you noticed a shift in the way we view women’s sexual health since you first started on the journey with Addyi?

• The term "pink pill" is often used metaphorically for gender-specific health solutions.
• Ongoing research aims to develop more effective, safe female libido enhancers.
• Cultural acceptance of such pills varies globally, affecting accessibility.
• Awareness about female sexual health continues to grow, driving demand.

Cindy Eckert: The shift that’s happening in women’s health is undeniable. And it’s happening because women are demanding better. I’d love to say it’s because the medical establishment has woken up and they’re proactively discussing this with women. Women are walking in and demanding, frankly, what they deserve. Literally the first headlines around Addyi were along the lines of “Female Viagra … Isn’t That Jewelry?” It’s unthinkable that that was less than a decade ago. Today, women tag their partners in ads for Addyi and publicly declare, “This is me!” HealthyWomen: Tell us about the idea behind The Pink Ceiling. Cindy Eckert: Well, it’s everything I wanted but didn't have access to when I was starting companies. As a founder, I can get to an outcome and I can reach my hand back and get more founders to that outcome, and they can reach their hands back and get more founders that outcome. I'm so grateful that people share their wild ideas with me of how they want to change the world. I see it as a great privilege to be able to do it and hopefully in some small way contribute to changing women’s health on a much greater basis. HealthyWomen: What can we expect to see next from The Pinkubator? Cindy Eckert: One of our companies just got clearance on a device that will revolutionize the epidural.

Why did it take so long to earn FDA approval for Addyi in the first place?

But like many advancements in women's healthcare, the road wasn’t easy. For one, it took Eckert six years to get FDA approval for Addyi. To put that into perspective, Viagra was approved in six months (more on that below). In 2015, Eckert sold Sprout Pharmaceuticals for $1 billion. But when the company that took over failed to launch the drug, Eckert couldn’t just walk away and let all those pink possibilities collect dust somewhere.

Related support groups

By 2018, she regained her role as CEO and launched Addyi herself. The “pink pill” disrupted the medical industry but it’s just one of the projects Eckert is part of. She’s also founder and CEO of The Pink Ceiling, an organization that runs The Pinkubator, which helps fund innovations in women’s healthcare. One example: the world’s first flushable pregnancy test. Eckert is perhaps most passionate about helping women succeed.

Drug Interactions

As you can probably imagine, our “15 minutes” turned into nearly an hour talking about everything from low libido to what we can expect from The Pinkubator in the near future. Our interview follows, edited for clarity and length. HealthyWomen: It took you six years to get FDA approval for Addyi. Why did it take six months for Viagra to get approved? We value sexual satisfaction for men culturally and dismiss it for women. It’s a mapping device for the spine that will guide you to exactly the right place the first time. It will change the patient experience and frankly change the cost of healthcare. HealthyWomen: What’s your advice for the next innovator or tadalis 20 person who may be looking to start a new career later in life? About the Change to the Female Libido Pill Warning - HealthyWomen › Flibanserin: Will It Ever Become the Female Viagra? Move over, little blue pill, we ladies now have our own version of – the little pink pill. For decades, we’ve been inundated (sometimes, even comically) with commercials and information about male sexual function and sexual health.

While this is all well and good, very little attention was paid to the female counterpart to sexual well-being and the fact that women sometimes need a little help too. Whether it’s simply a low sex drive, experienced by roughly 33% of women, or something that manifests physically like painful intercourse, affecting a whopping 75% of women during their lifetime, female sexual dysfunction is an issue that is finally getting the attention it deserves. So what does this little pink pill (referred to as “female viagra” and called Flibanserin) do? Because a woman’s libido relies on a complexity of factors such as emotional, environmental, and physical health, the drug is thought to be beneficial because it alters dopamine and serotonin levels in the brain. In studies, the female participants reported an increase in the number of sexually satisfying events each month, which is a promising statistic.

The research behind the “pink pill”

I’d like to say that it’s changing, but in order for the blue pill to have received rare fast track status for a six-month approval, male sexual satisfaction was deemed to be such an important unmet medical need that we reviewed a solution for it on an accelerated timeline. Erectile dysfunction is men’s most common sexual dysfunction. HSDD is the most common sexual dysfunction in women. And yet, it took just six months compared to six years to get a treatment for erectile dysfunction approved. It speaks volumes to how we have valued sexual satisfaction for men versus women.

Is Lack of Desire all in Our Heads??

And really, when you think about the data, more women than men actually suffer from sexual dysfunction — 43% of women compared to 31% of men. But we don't see it as an important need, and therefore innovation is so far behind. HealthyWomen: From comments online and social media, it seems a lot of women don’t even know sexual dysfunction is a thing — they think that the loss of sex drive is just part of aging. Cindy Eckert: In women’s health, I’d like to replace the word normal with common. There is a great survey by a woman named Marcella Hill, and she’s been very open online about her libido … She said she felt dead inside.

What are the serious side effects of Addyi?

She asked her doctor if there’s anything she can do. And she asked other women what their doctors said. And a majority [of the doctors] told the women their lack of interest in sex drive is normal. Zero of them said it could be biological and, for that, we have cenforce 150 uk a solution. Again, we can have discussions about date nights and those things, but not at the expense of biology. Flibanserin was approved by the FDA in August 2015 and will be available to patients in October 2015. Dr. Brady would be happy to review whether it is a viable option for you. It is important, as with any medication to weigh the benefits against potential side effects and alternative treatments. Specifically, it is important to avoid alcoholic beverages if a patient chooses to take Flibanserin. Which leads us to the alternative treatments… Many women aren’t aware of the various treatment options for female sexual health. For example, hormone replacement therapy has been shown to significantly improve a woman’s libido. For our patients who are experiencing physical issues such as painful intercourse due to vaginal dryness, MonaLisa Touch™ therapy has been life-changing (we have a 100% satisfaction rate among our patients!). Regardless of the reasons for a woman’s lack of sexual motivation, we can help get to the root of the problem and get our patients started on the appropriate treatment.

A healthy sex life is an important part of our emotional and overall wellness, and we can get you back into the groove! While sexual dysfunction affects both men and women, men have 26 FDA-approved treatments to choose from. A new documentary explains that it’s in part because the FDA drug approval process determines which sexual health options are available, and how restrictions or labeling decisions can limit access for certain groups. “When you look at women — premenopausal, postmenopausal, transgender individuals — the conversation of what is available to you is not dictated by you,” explains Johns Hopkins Carey Business School Law and Ethics Professor Stacey Lee in The Pink Pill: Sex, Drugs & Who Has Control.

i am no longer interested in masturbating

HealthyWomen: What kept you going through the tough times? Maybe I should have known the road to the first drug for women’s pleasure would be a bumpy one. The science has fueled me to keep going. HealthyWomen: Tell us one thing you want women to know about Addyi. Cindy Eckert: It’s not female Viagra — it’s so much more interesting! Addyi, or flibanserin, treats Hypoactive Sexual Desire Disorder, a common condition defined by lack of sexual desire in women. It has yet to achieve the same kind of widespread use or acceptance as men’s Viagra, which is used by millions of patients annually since its 1998 debut.

What does this approval mean for other women’s health products?

HealthyWomen: After Addyi was approved by the FDA, you sold the company for $1 billion. (Big congratulations.) You’ve since gotten the company back and relaunched the drug on your own terms. Cindy Eckert: It was an entrepreneur's dream come true to find a global company who could make this [drug] accessible to all of the women who needed it but for reasons in their own company, they never launched it. And I deeply felt that I was letting women down because I was fortunate enough that so many women had shared their stories with me and people let their guard down and they shared something very personal. And so I just decided — not on my watch.

IN CLINICAL TRIALS1, WOMEN ON ADDYI EXPERIENCED:

So, I'm so proud that I went back to the company. I'm going to launch it.” And now, to watch how many women’s lives it’s already impacted for the better — that’s what it was always about in the first place, right? I certainly didn't do this to get a drug approved. I did it so that we would level the playing field by changing the conversation about women and sex. And so the women who need help could get it easily. The Pink Pill recounts the journey of Sprout Pharmaceuticals Founder and CEO Cindy Eckert, the entrepreneur whose company developed and brought Addyi to market, as she set out to expand access for sexual health treatments for women. Eckert’s path in developing Addyi for patient use was more of a struggle than it should’ve been, according to the documentary, which calls out the inequalities in availability of sexual health treatment between men and women.

• Some pink pills combine herbal extracts like ginseng or maca for effects.
• They are popular in wellness circles for enhancing intimacy and confidence.
• Research on pink pills' long-term safety is limited; caution is advised.
• Available through online stores, pharmacies, or clinics in some regions.